Search

Desmond D Mascarenhas

from Auburn, CA
Age ~70
Get Report
Also known as:
Desmond Das Merces Mascarenhas, Desnond D Mascarenhas, Desmond Charkowicz, Desmond S
Phone and address:
11994 Torrey Pines Dr, Auburn, CA 95602
Related to:
Leon Charkowicz, 62Edwin Charkowicz, 98Brian CharkowiczLeon Charkowicz, 76Michelle Charkowicz, 37
Connected to:
Allwyn S Mascarenhas, 56Angela Mascarenas, 78Cheryl M Mascarenhas, 60David J Mascarenhas, 70Francisco J Mascarenas, 64Gabriel Mascarenhas, 46Gregory K Mascarenas, 67Henry J Mascarenas, 39Jose I Mascarell, 52Juan C Mascarello, 56

Desmond Mascarenhas Phones & Addresses

  • 11994 Torrey Pines Dr, Auburn, CA 95602
  • Sunnyvale, CA
  • 27223 Sherlock Rd, Los Altos Hills, CA 94022 (650) 948-5975
  • 27 Maplewood Dr, San Rafael, CA 94901
  • Santa Clara, CA
  • 1055 Escalon Ave APT 1105, Sunnyvale, CA 94085

Work

Position: Sales Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Desmond Mascarenhas Photo 1

Chairman And Chief Executive

View page
Location:
Sunnyvale, CA
Industry:
Biotechnology
Work:
Mayflower Organization For Research & Education Jan 2008 - Oct 2015
President
Ontherix Jan 2003 - Dec 2014
Founder and Chief Executive Officer
Transporin Jan 2003 - Dec 2014
Chairman and Chief Executive
Bioexpertise 2000 - 2014
Founder and Chief Executive Officer
Protigen Jan 1999 - Dec 2013
Founder and Chief Executive Officer
Education:
University of Oxford
Doctorates, Doctor of Philosophy, Biochemistry Stanford University
Skills:
Biotechnology
Start Ups
Entrepreneurship
Business Development
Lifesciences
Oncology
Management
Life Sciences
Product Development
R&D
Public Speaking
Immunology
Business Strategy
Strategic Consulting
Strategic Thinking
Strategic Planning
Languages:
Portuguese
Desmond Mascarenhas Photo 2

Desmond Mascarenhas

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Desmond D. Mascarenhas
President
Ipreferent, Inc
Nonclassifiable Establishments
428 Oakmead Pkwy, Sunnyvale, CA 94085
Desmond D. Mascarenhas
President
ONTHERIX, INC
Nonclassifiable Establishments
428 Oakmead Pkwy, Sunnyvale, CA 94085
525 Del Rey Ave, Sunnyvale, CA 94085
Desmond D. Mascarenhas
President
MAYFLOWER ORGANIZATION FOR RESEARCH AND EDUCATION
Noncommercial Research Organization
428 Oakmead Pkwy, Sunnyvale, CA 94085
525 Del Rey Ave, Sunnyvale, CA 94085
Desmond D. Mascarenhas
President
BIOEXPERTISE, INC
Provide Knowledge Management Services to Biopharma Industries
525 Del Rey Ave STE B, Sunnyvale, CA 94085
(408) 523-6279
Desmond D. Mascarenhas
President
PROTIGEN INC
Research Education and Consulting Services
525 Del Rey Ave SUITE B, Sunnyvale, CA 94085
(408) 523-6279
Desmond Mascarenhas
Bioexpertise, LLC
Educational Services
325 E Middlefield Rd, Mountain View, CA 94043

Publications

Isbn (Books And Publications)

Biopharmaceutical Drug Development Strategies, Technologies, And Trends

View page
Author

Desmond Mascarenhas

ISBN #

0849337291

Us Patents

Insulin-Like Growth Factor Binding Protein Variants

View page
US Patent:
6417330, Jul 9, 2002
Filed:
May 27, 1999
Appl. No.:
09/322484
Inventors:
Desmond Mascarenhas - Los Altos Hills CA
David Passmore - Albany CA
Stephen Danko - San Francisco CA
Assignee:
Celtrix Pharmaceuticals, Inc. - San Jose CA
International Classification:
C07K 1700
US Classification:
530350, 530399, 530324, 530303
Abstract:
The invention relates to variants of native insulin-like growth factor binding protein 3 (IGFBP-3). Variant IGFBP-3s are disclosed which are modified to be resistant to hydrolysis. Also disclosed are variant IGFBP-3s where the nuclear localization signal (NLS) in native IGFBP-3 is altered. Additionally, amino-terminally extended IGFBP-3s are disclosed which include a variety of N-terminal extensions, including peptide and nucleotide binding domains, specific binding members such as ligand binding domains from receptors or antigen binding domains from immunoglobins, and peptide and protein hormones and growth factors. N-terminally extended IGFBP-3s may comprise hydrolysis-resistant or NLS variant IGFBP-3s.

Method Of Treating Psychological And Metabolic Disorders Using Igf Or Igf/Igfbp-3

View page
US Patent:
6514937, Feb 4, 2003
Filed:
Jul 27, 1998
Appl. No.:
09/123217
Inventors:
Desmond Mascarenhas - Los Altos Hills CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Glen Allen VA
International Classification:
A61K 3830
US Classification:
514 12, 514 3, 514 2, 514 4, 4241981, 424520, 424537, 424546, 530303, 530324, 530333
Abstract:
Methods are provided for treating or alleviating the symptoms of subjects with psychological disorders, metabolic disorders, chronic stress-related disorders, sleep disorders, conditions associated with sexual senescence, aging, or premature aging by treating such subjects with IGF or mutant IGF either alone or complexed with IGFBP-3. Methods for increasing the levels of DHEA or DHEAS and treating or alleviating the symptoms of subjects with disorders characterized by low levels of DHEA or DHEAS by administering effective amounts of IGF or mutant IGF alone or complexed with IGFBP-3 are also provided. Methods for increasing the level of T4 and treating or alleviating the symptoms of subjects with disorders characterized by low levels of T3 or T4 by administering effective amounts of IGF or mutant IGF alone or complexed with IGFBP-3 are additionally provided. Also provided are methods for the treatment of polycystic ovarian syndrome (PCOS) by long term administration of IGF/IGFBP-3 complex.

Method Of Treating Psychological And Metabolic Disorders Using Igf Or Igf/Igfbp-3

View page
US Patent:
6518238, Feb 11, 2003
Filed:
Oct 15, 1999
Appl. No.:
09/418861
Inventors:
Desmond Mascarenhas - Los Altos Hills CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Glen Allen VA
International Classification:
C07K 1465
US Classification:
514 2, 514 12, 530399
Abstract:
Methods are provided for treating or alleviating the symptoms of subjects with psychological disorders, metabolic disorders, chronic stress-related disorders, sleep disorders, conditions associated with sexual senescence, aging, or premature aging by treating such subjects with IGF or mutant IGF either alone or complexed with IGFBP-3. Methods for increasing the levels of DHEA or DHEAS and treating or alleviating the symptoms of subjects with disorders characterized by low levels of DHEA or DHEAS by administering effective amounts of IGF or mutant IGF alone or complexed with IGFBP-3 are also provided. Methods for increasing the level of T4 and treating or alleviating the symptoms of subjects with disorders characterized by low levels of T3 or T4 by administering effective amounts of IGF or mutant IGF alone or complexed with IGFBP-3 are additionally provided.

Interactive Assessment Tool

View page
US Patent:
6808393, Oct 26, 2004
Filed:
Nov 21, 2001
Appl. No.:
09/990655
Inventors:
Desmond D. Mascarenhas - Los Altos Hills CA
Assignee:
Protigen, Inc. - Sunnyvale CA
International Classification:
G09B 300
US Classification:
434322, 434118, 434350, 434236
Abstract:
The present invention provides a method, system, and computer product to evaluate a users learning style. The user is presented with a series of interactive assessment exercises, wherein each exercise contains one or more clues, a number of correct cards, and a number of incorrect cards. The users responses, which include the types and number of moves made, the time it takes to select another card, and the like are received, recorded, or captured. Based on the users responses, the responses are evaluated and used in a learning style formula to determine the learning style of a user. The invention also provides for a method, system, and computer product that evaluate a users comprehension of a certain topic or subject matter. The user is presented with an interactive assessment exercise, wherein such exercise contains one or more clues, a number of correct cards, and a number of incorrect cards.

Igf-Binding Protein-Derived Peptide

View page
US Patent:
6861406, Mar 1, 2005
Filed:
Aug 9, 2002
Appl. No.:
10/215759
Inventors:
Desmond Mascarenhas - Los Altos Hills CA, US
Assignee:
Bioexpertise, LLC - Sunnyvale CA
International Classification:
A61K038/00
US Classification:
514 12
Abstract:
New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.

Igf-Binding Protein-Derived Peptide

View page
US Patent:
6887851, May 3, 2005
Filed:
Oct 4, 2002
Appl. No.:
10/264672
Inventors:
Desmond Mascarenhas - Los Altos Hills CA, US
Assignee:
Bioexpertise, LLC - Sunnyvale CA
International Classification:
A61K038/00
US Classification:
514 12
Abstract:
New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.

Igf-Binding Protein-Derived Peptide Or Small Molecule

View page
US Patent:
6914049, Jul 5, 2005
Filed:
Mar 7, 2003
Appl. No.:
10/383999
Inventors:
Desmond Mascarenhas - Los Altos Hills CA, US
Assignee:
Bioexpertise, LLC - Sunnyvale CA
International Classification:
A61K038/00
US Classification:
514 12, 435 6
Abstract:
New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.

Computer Implemented Searching Using Search Criteria Comprised Of Ratings Prepared By Leading Practitioners In Biomedical Specialties

View page
US Patent:
7058516, Jun 6, 2006
Filed:
Jul 16, 2001
Appl. No.:
09/906888
Inventors:
Desmond D. Mascarenhas - Los Altos Hills CA, US
Assignee:
Bioexpertise, Inc. - Sunnyvale CA
International Classification:
G06F 7/00
G06F 17/00
G06F 19/00
US Classification:
702 19, 707 1, 707101, 707102
Abstract:
The present invention provides a system and method for creating and maintaining a Biomedical document database, wherein the documents have been reviewed by biomedical and other experts, who have assigned taxonomic based indicia to each document wherein a specialized search engine can rapidly retrieve relevant documents based upon the commnly known taxonomy.
Control profile
Desmond D Mascarenhas from Auburn, CA, age ~70 Get Report